Wednesday,  July 18, 2012 • Vol. 13--No. 005 • 23 of 30 •  Other Editions

(Continued from page 22)

Vladimir Putin on Tuesday.
• ___

Obama administration plans $1 billion to reward top teachers in math, science and engineering

• WASHINGTON (AP) -- The Obama administration unveiled plans Wednesday to create an elite corps of master teachers, a $1 billion effort to boost U.S. students' achievement in science, technology, engineering and math.
• The program to reward high-performing teachers with salary stipends is part of a long-term effort by President Barack Obama to encourage education in high-demand areas that hold the key to future economic growth -- and to close the achievement gap between American students and their international peers.
• Teachers selected for the Master Teacher Corps will be paid an additional $20,000 a year and must commit to participate multiple years. The goal is to create a multiplier effect in which expert educators share their knowledge and skills with other teachers, improving the quality of education for all students.
• Speaking at a rally for his re-election campaign in San Antonio on Tuesday, Obama framed his emphasis on expanded education funding as a point of contrast with Republican challenger Mitt Romney, whom he accused of prioritizing tax cuts for the wealthy over reinvestment in the nation.
• "I'm running to make sure that America has the best education system on earth, from pre-K all the way to post-graduate," Obama said. "And that means hiring new

teachers, especially in math and science."
• ___

FDA approves Vivus' anti-obesity pill associated with significant weight loss in patients

• WASHINGTON (AP) -- A new weight-loss pill that many doctors consider the most effective of a new generation of anti-obesity drugs got the approval of the Food and Drug Administration on Tuesday.
• The pill, called Qsymia, was approved for patients who are overweight or obese and also have at least one weight-related condition such as high blood pressure, diabetes or high cholesterol.
• The drug offers hope for those who have failed to lose weight in other ways, but its path to approval also underscores how difficult it has been for drugmakers to find obesity treatments that are safe and effective.

(Continued on page 24)

© 2012 Groton Daily Independent • To send correspondence, click here.